About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Melanoma Clinical Trials in Maryland | 303 Studies

Clinical Trials MelanomaMaryland

Melanoma Clinical Trials in Maryland

Find 303 clinical trials for melanoma near Maryland. Connect with research centers in your area.

All Melanoma trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 81-100 of 303 trials

TerminatedAnti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced MelanomaBackground: * Melanoma antigen recognized by T-cells (MART)-1 is a protein present in melanoma cells.NCT00612222·Bethesda, Maryland TerminatedAutologous Dendritic Cell-Tumor Cell Immunotherapy for Metastatic MelanomaThe purpose of this research is to evaluate the safety and effectiveness of tumor cell therapy.NCT01875653·Irvine, California and 17 others

Melanoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingTesting Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has SpreadThis phase II trial compares the effect of dabrafenib and trametinib given continuously to given with a break in treatment (intermittent) in treating patients with stage III-IV…NCT02196181·Birmingham, Alabama and 751 others

TerminatedAnti-MART-1 F5 Lymphocytes to Treat High-Risk Melanoma PatientsBackground: * Melanoma antigen recognized by T cells (MART-1) is a gene that is present in melanoma cells.NCT00706992·Bethesda, Maryland

CompletedLymphocyte-Depleting Nonmyeloablative Preparative Chemotherapy Followed By Autologous Lymphocyte Infusion, Peptide Vaccine Plus Montanide ISA-51, and Interleukin-2 in Treating Patients With Metastatic MelanomaRATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and fludarabine, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00079144·Bethesda, Maryland and 1 other

Terminated0794GCC: Pentamidine in Treating Patients With Relapsed or Refractory MelanomaRATIONALE: Drugs used in chemotherapy, such as pentamidine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00729807·Baltimore, Maryland

CompletedCyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic MelanomaRATIONALE: Drugs used in chemotherapy, such as cyclophosphamide and fludarabine, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00096382·Bethesda, Maryland and 1 other

UnknownSafety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesThe primary objective is to assess the safety and tolerability of TAB004 as monotherapy and in combination with toripalimab in subjects with selected advanced solid malignancies…NCT04137900·Birmingham, Alabama and 23 others

Active not recruitingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy…NCT04485013·Tucson, Arizona and 40 others

CompletedLMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By SurgeryRATIONALE: The LMB-2 immunotoxin can find tumor cells and kill them without harming normal cells.NCT00295958·Bethesda, Maryland and 1 other

CompletedUsing High Resolution Function Imaging To Detect Melanoma and Dysplastic NeviA novel infrared imaging tool to aid in the clinical detection of atypical pigmented lesions and melanoma is developed.NCT01118832·Baltimore, Maryland

Active not recruitingA Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable MelanomaThe purpose of this study is to demonstrate that the study drug exposure level of the nivolumab + relatlimab FDC subcutaneous (SC) formulation is not worse than nivolumab +…NCT05625399·Phoenix, Arizona and 148 others

CompletedNivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasThis phase I/II trial studies the side effects and best dose of nivolumab when given with or without ipilimumab to see how well they work in treating younger patients with solid…NCT02304458·Birmingham, Alabama and 24 others

CompletedAldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic MelanomaThis randomized phase III trial studies aldesleukin with vaccine therapy to see how well it works compared to aldesleukin alone in treating patients with melanoma that has spread…NCT00019682·Birmingham, Alabama and 18 others

CompletedSurvivorship Promotion In Reducing IGF-1 TrialThis is a prospective, single-center randomized trial with three arms, and an allocation ratio of 1:1:1.NCT02431676·Baltimore, Maryland

CompletedNatural Killer Cells Plus IL-2 Following Chemotherapy to Treat Advanced Melanoma or Kidney CancerBackground: * Natural killer (NK) cells are large lymphocytes (a type of white blood cell) that are important in the immune response to cancer.NCT00328861·Bethesda, Maryland

TerminatedImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaBackground: * The National Cancer Institute (NCI) Surgery Branch has developed an experimental therapy that involves taking white blood cells from patients' tumors, growing them…NCT01468818·Bethesda, Maryland

No longer availableExpanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to LiverThe safety and efficacy of CS-PHP-melphalan has been evaluated in a phase 3 trial conducted in the same patient population as well as using the same melphalan dosing as proposed…NCT01728051·Santa Monica, California and 5 others

CompletedChemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat MelanomaBackground: This study uses a new experimental procedure for treating melanoma that uses the patient's own lymphocytes (type of white blood cell), which are specially selected to…NCT00665470·Bethesda, Maryland

CompletedVaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid TumorsRATIONALE: Vaccines made from a peptide may make the body build an immune response to kill tumor cells.NCT00019331·Bethesda, Maryland

PreviousPage 5 of 16Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Leukemia Lymphoma